Literature DB >> 22985697

Structural modification of siRNA for efficient gene silencing.

So Jin Lee1, Sejin Son, Ji Young Yhee, Kuiwon Choi, Ick Chan Kwon, Sun Hwa Kim, Kwangmeyung Kim.   

Abstract

Small interfering RNA (siRNA) holds a great promise for the future of genomic medicine because of its highly sequence-specific gene silencing and universality in therapeutic target. The medical use of siRNA, however, has been severely hampered by the inherent physico-chemical properties of siRNA itself, such as low charge density, high structural stiffness and rapid enzymatic degradation; therefore, the establishment of efficient and safe siRNA delivery methodology is an essential prerequisite, particularly for systemic administration. For an efficient systemic siRNA delivery, it is a critical issue to obtain small and compact siRNA polyplexes with cationic condensing reagents including cationic polymers, because the size and surface properties of the polyplexes are major determinants for achieving desirable in vivo fate. Unfortunately, synthetic siRNA is not easily condensed with cationic polymers due to its intrinsic rigid structure and low spatial charge density. Accordingly, the loose siRNA polyplexes inevitably expose siRNA to the extracellular environment during systemic circulation, resulting in low therapeutic efficiency and poor biodistribution. In this review, we highlight the innovative approaches to increase the size of siRNA via structural modification of the siRNA itself. The attempts include several methodologies such as hybridization, chemical polymerization, and micro- and nano-structurization of siRNA. Due to its increased charge density and flexibility, the structured siRNA can produce highly condensed and homogenous polyplexes compared to the classical monomeric siRNA. As a result, stable and compact siRNA polyplexes can enhance serum stability and target delivery efficiency in vivo with desirable biodistribution. The review specifically aims to provide the recent progress of structural modification of siRNA. In addition, the article also briefly and concisely explains the improved physico-chemical properties of structured siRNA with respect to stability, condensation ability and gene silencing efficiency.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985697     DOI: 10.1016/j.biotechadv.2012.09.002

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  12 in total

1.  Transferrin-Dressed Virus-like Ternary Nanoparticles with Aggregation-Induced Emission for Targeted Delivery and Rapid Cytosolic Release of siRNA.

Authors:  Tingbin Zhang; Weisheng Guo; Chunqiu Zhang; Jing Yu; Jing Xu; Shuyi Li; Jian-Hua Tian; Paul C Wang; Jin-Feng Xing; Xing-Jie Liang
Journal:  ACS Appl Mater Interfaces       Date:  2017-05-03       Impact factor: 9.229

Review 2.  Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Authors:  Xiaoxin Li; Hongzhao Qi; Weigang Cui; Zhibin Wang; Xiuxiu Fu; Tianxiang Li; Huibo Ma; Yanyan Yang; Tao Yu
Journal:  Mol Ther       Date:  2022-08-01       Impact factor: 12.910

Review 3.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

Review 4.  Delivery strategies and potential targets for siRNA in major cancer types.

Authors:  So Jin Lee; Min Ju Kim; Ick Chan Kwon; Thomas M Roberts
Journal:  Adv Drug Deliv Rev       Date:  2016-05-31       Impact factor: 15.470

Review 5.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

6.  Efficient delivery of NF-κB siRNA to human retinal pigment epithelial cells with hyperbranched cationic polysaccharide derivative-based nanoparticles.

Authors:  Zhenzhen Liu; Haijun Gong; Rui Zeng; Xuan Liang; Li-Ming Zhang; Liqun Yang; Yuqing Lan
Journal:  Int J Nanomedicine       Date:  2015-04-07

7.  Silencing of Survivin Expression Leads to Reduced Proliferation and Cell Cycle Arrest in Cancer Cells.

Authors:  Yuhuan Li; Da Liu; Yulin Zhou; Yujing Li; Jing Xie; Robert J Lee; Yong Cai; Lesheng Teng
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

8.  Gold nanorods/siRNA complex administration for knockdown of PARP-1: a potential treatment for perinatal asphyxia.

Authors:  Valentina Vio; Ana L Riveros; Andrea Tapia-Bustos; Carolyne Lespay-Rebolledo; Ronald Perez-Lobos; Luis Muñoz; Paola Pismante; Paola Morales; Eyleen Araya; Natalia Hassan; Mario Herrera-Marschitz; Marcelo J Kogan
Journal:  Int J Nanomedicine       Date:  2018-10-25

9.  Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.

Authors:  Jianye Liu; Yi Zhang; Qinghai Zeng; Hongliang Zeng; Xiaoming Liu; Pei Wu; Hongyi Xie; Leye He; Zhi Long; Xiaoyong Lu; Mengqing Xiao; Yuxing Zhu; Hao Bo; Ke Cao
Journal:  Sci Adv       Date:  2019-09-25       Impact factor: 14.136

10.  Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.

Authors:  Mihue Jang; Jong Hwan Kim; Hae Yun Nam; Ick Chan Kwon; Hyung Jun Ahn
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.